| Fibrin-bound thrombin determines clot structure and blood thrombogenicity in normofibrinogenemia and dysfibrinogenemia | Haematologica |  | | 2026 | 14 | 16 |
|
| Fibrinogen Dusart Escapes Clauss‐ CWA Screening in a Genotype‐Confirmed Dysfibrinogenemia Cohort | International journal of laboratory hematology |  | | 2026 | 1 | 0 |
|
| Standardization of scanning electron microscopy analysis of fibrin fiber diameter measurement : communication from the ISTH SSC subcommittee on FXIII and fibrinogen | Journal of thrombosis and haemostasis | | | 2026 | 3 | 31 |
|
| The Hypofibrinolysis State Associated with the Dysfibrinogenemia Dusart is Mainly Related to the Altered Fibrin Clot Structure | Hämostaseologie | | | 2026 | 11 | 242 |
|
| Perinatal stroke and hypofibrinogenemia : Is the new missense fibrinogen variant γ p.Gly310Glu the cause of the procoagulant state ? | Thrombosis research | | | 2024 | 100 | 0 |
|
| Diagnostic value of clot formation parameters determined by rotational thromboelastometry in 63 patients with congenital dysfibrinogenemia | Blood coagulation & fibrinolysis | | | 2024 | 102 | 275 |
|
| Physiological correction of hereditary mild hypofibrinogenemia during pregnancy | Haemophilia | | | 2023 | 221 | 673 |
|
| Pharmacodynamics Monitoring of Emicizumab in Patients with Hemophilia A | Thrombosis and haemostasis | | | 2023 | 185 | 0 |
|
| Impact of fibrinogen infusion on thrombin generation and fibrin clot structure in patients with inherited afibrinogenemia | Thrombosis and haemostasis | | | 2022 | 180 | 2 |
|
| Fibrin clot properties to assess the bleeding phenotype in unrelated patients with hypodysfibrinogenemia due to novel fibrinogen mutations | Thrombosis research | | | 2021 | 589 | 5 |
|
| Comparison of different activators of coagulation by turbidity analysis of hereditary dysfibrinogenemia and controls | Blood Coagulation and Fibrinolysis | | | 2021 | 235 | 0 |
|
